PepGen (PEPG) Current Assets (2021 - 2026)
PepGen (PEPG) reported Current Assets of $134.3 million for Q1 2026, up 32.88% on a YoY basis from $101.0 million in Q1 2025, and down 11.06% sequentially from $151.0 million in Q4 2025.
PepGen (PEPG) Current Assets (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Current Assets data on file, last reported at $134.3 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 32.88% year-over-year to $134.3 million; the trailing twelve-month figure through Mar 2026 stood at $134.3 million (up 32.88% YoY), and the FY2025 full-year result was $151.0 million, up 21.98% from the prior year.
- Current Assets slipped to $134.3 million in Q1 2026, from $151.0 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $226.5 million in Q2 2022 to a low of $77.5 million in Q2 2025.
- A 5-year average of $149.7 million and a median of $150.4 million in 2023 frame the typical range for Current Assets.
- Across the five-year window, Current Assets jumped 34.06% in 2023 and plunged 52.98% in 2025, its largest moves.
- Tracing PEPG's Current Assets over 5 years: stood at $186.1 million in 2022, then plunged by 39.45% to $112.7 million in 2023, then gained by 9.84% to $123.8 million in 2024, then rose by 21.98% to $151.0 million in 2025, then declined by 11.06% to $134.3 million in 2026.
- Business Quant data shows PEPG's Current Assets at $134.3 million in Q1 2026, $151.0 million in Q4 2025, and $166.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | 134.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134.27 Mn |
| Dec 31, 2025 | 150.96 Mn |
| Sep 30, 2025 | 166.21 Mn |
| Jun 30, 2025 | 77.49 Mn |
| Mar 31, 2025 | 101.05 Mn |
| Dec 31, 2024 | 123.76 Mn |
| Sep 30, 2024 | 142.37 Mn |
| Jun 30, 2024 | 164.78 Mn |
| Mar 31, 2024 | 177.62 Mn |
| Dec 31, 2023 | 112.68 Mn |
| Sep 30, 2023 | 133.09 Mn |
| Jun 30, 2023 | 150.38 Mn |
| Mar 31, 2023 | 168.47 Mn |
| Dec 31, 2022 | 186.08 Mn |
| Sep 30, 2022 | 204.25 Mn |
| Jun 30, 2022 | 226.48 Mn |
| Mar 31, 2022 | 125.67 Mn |
| Dec 31, 2021 | 139.99 Mn |